USCDI Export for the Public
| Classification Level Sort descending | Data Class | Data Class Description | Data Element | Data Element Description | Applicable Standards | Submitter Name | Submitter Organization | Submission Date |
|---|---|---|---|---|---|---|---|---|
| Draft USCDI V2 | Information about a person who participates or is expected to participate in the care of a patient. |
Care Team Member Name | Al Taylor | ONC | ||||
| Draft USCDI V2 | Information about a person who participates or is expected to participate in the care of a patient. |
Care Team Member Identifier | Al Taylor | ONC | ||||
| Draft USCDI V2 | Data used to categorize individuals for identification, records matching, and other purposes. |
Last Name | ||||||
| Draft USCDI V2 | Data used to categorize individuals for identification, records matching, and other purposes. |
Preferred Language | Request for Comment (RFC) 5646, “Tags for Identifying Languages”, September 2009 Adopted at 45 CFR 170.207(g) |
|||||
| Draft USCDI V2 | Record of vaccine administration. |
Immunizations |
|
|||||
| Draft USCDI V2 | Tests that result in visual images requiring interpretation by a credentialed professional. |
Imaging Narrative |
Contains a consulting specialist’s interpretation of diagnostic imaging data. This data element was reclassified from Clinical Notes to Diagnostic Imaging. |
Logical Observation Identifiers Names and Codes (LOINC®) version 2.69
|
||||
| Draft USCDI V2 | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Systolic Blood Pressure | Both standards are required.
|
|||||
| Draft USCDI V2 | Harmful or undesired physiological responses associated with exposure to a substance. |
Substance (Medication) |
|
|||||
| Draft USCDI V2 | Activity performed for or on a patient as part of the provision of care. |
Procedures |
Optional:
|
|||||
| Draft USCDI V2 | Data used to categorize individuals for identification, records matching, and other purposes. |
Phone Number Type | ||||||
| Draft USCDI V2 | The metadata, or extra information about data, regarding who created the data and when it was created. |
Author Time Stamp | ||||||
| Draft USCDI V2 | Pharmacologic agents used in the diagnosis, cure, mitigation, treatment, or prevention of disease. |
Medications |
|
|||||
| Draft USCDI V2 | The metadata, or extra information about data, regarding who created the data and when it was created. |
Author Organization | Organization associated with author. |
|||||
| Draft USCDI V2 | Analysis of clinical specimens to obtain information about the health of a patient. |
Values/Results | Documented findings of the analysis of a tested specimen. Includes both structured and unstructured (narrative) components. |
|||||
| Draft USCDI V2 | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Head Occipital-frontal Circumference Percentile (Birth - 36 Months) |
|
|||||
| Draft USCDI V2 | Condition, diagnosis, or reason for seeking medical attention. |
Problems |
|
|||||
| Draft USCDI V2 | Representing a patient’s smoking behavior. |
Smoking Status | Representing a patient’s smoking behaviors. |
|
||||
| Draft USCDI V2 | Data used to categorize individuals for identification, records matching, and other purposes. |
First Name | ||||||
| Draft USCDI V2 | Analysis of clinical specimens to obtain information about the health of a patient. |
Tests | The name of the analysis of specimens derived from humans which provide information for the diagnosis, prevention, treatment of disease, or assessment of health. |
|
||||
| Draft USCDI V2 | Data used to categorize individuals for identification, records matching, and other purposes. |
Email Address |
